v3.19.2

Balance Sheets - USD ($)	Feb. 28, 2019	Feb. 28, 2018
Current Assets:
Cash	$ 36,542	$ 56,407
Prepaid expenses	21,726	5,000
Total current assets	58,268	61,407
Deposit	19,219	19,219
TOTAL ASSETS	77,487	80,626
Current liabilities:
Accounts payable	21,595	27,319
Deferred Rent	8,167	0
Due to related party	1,600	1,600
Accrued payroll - related parties	38,500	35,175
Accrued payroll - non-related parties	6,216	17,039
Notes payable and accrued interest	0	45,000
Related party notes payable and accrued interest	0	226,299
TOTAL LIABILITIES	76,078	352,433
Commitments and contingencies
Stockholders' equity (deficit):
Preferred stock, $0.001 par value, 10,000,000 shares authorized; none issued and outstanding at February 28, 2019 and 2018, respectively	0	0
Common stock, $0.001 par value, 190,000,000 shares authorized; 15,510,646 and 13,510,646 shares issued and outstanding at February 28, 2019 and 2018, respectively	15,510	13,510
Additional paid-in capital	2,922,682	1,940,526
Accumulated deficit	(2,936,783)	(2,225,843)
Total stockholders' equity (deficit)	1,409	(271,807)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY/ (DEFICIT)	$ 77,487	$ 80,626

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

US-China Biomedical Technology, Inc. 10-K